News & Perspective

Mar 30, 2012

Mar 30, 2012

NSABB reverses recommendation on H5N1 studies

(CIDRAP News) – A federal advisory board today reversed its stance on publishing two controversial H5N1 transmission papers today, recommending that both studies be published in full.

The National Science Advisory Board for Biosecurity (NSABB) met yesterday and today to discuss revised versions of the studies by two groups, one from the University of Wisconsin, Madison, and one from Erasmus University in the Netherlands.

Mar 29, 2012

Mar 29, 2012

US debuts life sciences dual-use research policy

(CIDRAP News) – Federal health officials today unveiled a new policy for overseeing life sciences dual-use research, such as two recent H5N1 transmission studies that have sparked bioterror concerns as well as cries of censorship.

Mar 28, 2012

Mar 28, 2012

Experts call for overhaul of global flu surveillance

(CIDRAP News) – In a set of articles published today in Nature, influenza experts say global flu surveillance—especially in poultry and swine—is sorely lacking and needs a major overhaul to make it more sustained, timely, and representative.

Mar 28, 2012

Mar 28, 2012

Scientists volley ahead of more dual-use H5N1 debate

(CIDRAP News) – As researchers from both sides of the debate over two controversial H5N1 studies weighed in yesterday on full publication versus a more cautionary approach, two US journals said they are developing policies to address any future such instances.

Mar 26, 2012

Mar 26, 2012

Fouchier anticipates resuming H5N1 studies soon

(CIDRAP News) – The lead researcher of one of the controversial H5N1 avian influenza transmission studies in ferrets said today that he hopes scientists can resume work on the studies in about 2 weeks, after key groups have discussed the issues.

Pages

Sort Results By:

 Sort Results By:

Narrow results by:

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by

  Become an underwriter»